These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3452240)

  • 61. [Preventive measures for the control of fungal infections in the clinic].
    Seeliger HP; Schröter G
    Immun Infekt; 1984 Jun; 12(3):143-50. PubMed ID: 6398797
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy of selective bowel decontamination as infection prevention after liver transplantation.
    Rosman C; Klompmaker IJ; Bonsel GJ; Bleichrodt RP; Arends JP; Slooff MJ
    Transplant Proc; 1990 Aug; 22(4):1554-5. PubMed ID: 2389398
    [No Abstract]   [Full Text] [Related]  

  • 63. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.
    Sleijfer DT; Mulder NH; de Vries-Hospers HG; Fidler V; Nieweg HO; van der Waaij D; van Saene HK
    Eur J Cancer (1965); 1980 Jun; 16(6):859-69. PubMed ID: 6997054
    [No Abstract]   [Full Text] [Related]  

  • 64. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations.
    Steffen R; Reinhartz O; Blumhardt G; Bechstein WO; Raakow R; Langrehr JM; Rossaint R; Slama K; Neuhaus P
    Transpl Int; 1994; 7(2):101-8. PubMed ID: 8179797
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Levuroses appearing in cases of severe burns].
    Male O; Diem E
    Dermatologica; 1979; 159(1):113-9. PubMed ID: 385379
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
    Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S
    Infection; 1988; 16(2):98-104. PubMed ID: 3286509
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of chemoprophylaxis in the prevention of airborne infection by fungal pathogens.
    Hay RJ
    J Hosp Infect; 1991 Jun; 18 Suppl A():460-5. PubMed ID: 1679816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective decontamination of the gut--is it enough?
    Deitch EA
    Crit Care Med; 1990 Sep; 18(9):1043-4. PubMed ID: 2394106
    [No Abstract]   [Full Text] [Related]  

  • 69. Protected environment--prophylactic antibiotic programmes; microbiological studies.
    Bodey GP; Rodriguez V
    Clin Haematol; 1976 Jun; 5(2):395-408. PubMed ID: 780031
    [No Abstract]   [Full Text] [Related]  

  • 70. Opportunistic fungal and bacterial infection in the renal transplant recipient.
    Tolkoff-Rubin NE; Rubin RH
    J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S264-9. PubMed ID: 1498286
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Mycological studies of patients with hemoblastoses].
    Kaben U; Nowotny P; Günther I; Preussner S; Konrad H; Westphal HJ
    Z Gesamte Inn Med; 1977 Nov; 32(22):618-22. PubMed ID: 602313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Infections in acute leukemia].
    Garavelli PL
    Minerva Med; 1988 Apr; 79(4):261-2. PubMed ID: 3163413
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.
    Yamada T; Dan K; Nomura T
    Intern Med; 1993 Sep; 32(9):710-5. PubMed ID: 8142675
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Characteristic features of infections in hemoblastoses under cytostatic treatment (author's transl)].
    Paulisch R; Koeppen KM
    MMW Munch Med Wochenschr; 1976 May; 118(21):661-4. PubMed ID: 818543
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention and therapy of fungal infections in cancer patients. A review of recently published information.
    Klastersky J
    Support Care Cancer; 1995 Nov; 3(6):393-401. PubMed ID: 8564343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Fungal infections in liver transplantation].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1991; 9(6):317-9. PubMed ID: 1932237
    [No Abstract]   [Full Text] [Related]  

  • 77. Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients.
    Karp JE; Merz WG
    J Clin Oncol; 1986 Feb; 4(2):216-20. PubMed ID: 3944605
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective decontamination of the gut.
    Atkinson SW; Bihari DJ
    BMJ; 1993 Jan; 306(6873):286-7. PubMed ID: 8461643
    [No Abstract]   [Full Text] [Related]  

  • 79. Changes of immunological parameters in immunocompromised patients under selective decontamination of the digestive tract. Third Part: Behaviour of some plasma proteins.
    Wulf E; Koch H; Gille R
    Tokai J Exp Clin Med; 1989 Jun; 14(3):225-9. PubMed ID: 2484120
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selective decontamination in bone marrow transplant recipients.
    Guiot HF; van Furth R
    Epidemiol Infect; 1992 Dec; 109(3):349-60. PubMed ID: 1468520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.